Analyzing non-clinical pharmacokinetics (PK) and toxicokinetics (TK) is crucial in the early stages of drug development. A comprehensive grasp of the DMPK (Drug Metabolism and Pharmacokinetics) for a prospective clinical candidate can significantly influence the success of a drug discovery program. AmplifyBio's integrated services effortlessly handle in vivo sample generation and bioanalysis, providing an extensive array of TK and PK services tailored for small molecules, large molecules, peptides, and biologics.
AmplifyBio brings years of experience, ample resources, and flexible service options to deliver prompt and reliable support at any project phase. Our team of experts will help you select the optimal modeling methods and models for your data and is prepared to develop custom models as needed, ensuring a personalized approach to meet your specific needs.
Preclinical CRO services play a crucial role in drug development by conducting studies and experiments on potential therapeutics before they advance to clinical trials. AmplifyBio offers a wide-range of preclinical CRO services including:
As an expert contract research organization (CRO), AmplifyBio leverages decades of experience to create modern commercial drug development solutions. From CRO and preclinical CRO needs to cell and gene therapy and advanced therapy testing, our accredited team designs innovative paths to produce globally recognized studies, services, and more.